Adherence to oral therapies among patients with renal cell carcinoma: Post hoc analysis of the ECOG‐ACRIN E2805 trial von Murphy, Caitlin C., Fullington, Hannah M., Gerber, David E., Bowman, Isaac Alex, Puligandla, Maneka, Dutcher, Janice P., DiPaola, Robert S., Haas, Naomi B.

Volltext

Characterizing the outcomes of metastatic papillary renal cell carcinoma von Connor Wells, John, Donskov, Frede, Fraccon, Anna P., Pasini, Felice, Bjarnason, Georg A., Beuselinck, Benoit, Knox, Jennifer J., Rha, Sun Young, Agarwal, Neeraj, Bowman, Isaac Alex, Lee, Jae‐Lyun, Pal, Sumanta K., Srinivas, Sandy, Scott Ernst, Douglas, Vaishampayan, Ulka N., Wood, Lori A., Simpson, Robin, De Velasco, Guillermo, Choueiri, Toni K., Heng, Daniel Y. C.

Volltext

Active surveillance in metastatic renal cell carcinoma: A single-center cohort von Schwartzman, William, Elias, Roy, Govil, Malvika, Nosair, Waseem, Christie, Alana, Courtney, Kevin Dale, Bowman, Isaac Alex, Cole, Suzanne, Arafat, Waddah, Hammers, Hans J., Brugarolas, James

Volltext

Safety and efficacy of immune checkpoint inhibitors (ICI) in metastatic non-clear cell renal cell carcinoma (nccRCC): An institutional experience von Schwartzman, William, Elias, Roy, Patel, Viral M., Bowman, Alex Isaac, Chintalapati, Suneetha, Kapur, Payal, Hammers, Hans J., Brugarolas, James

Volltext

Phase II trial of stereotactic ablative radiation (SAbR) for oligoprogressive kidney cancer von Hannan, Raquibul, Christensen, Michael, Garant, Aurelie, Hammers, Hans J., Arafat, Waddah, Courtney, Kevin Dale, Bowman, Isaac Alex, Cole, Suzanne, Sher, David, Ahn, Chul, Timmerman, Robert D., Brugarolas, James

Volltext

Phase 1a/b open-label study of IK-175, an oral AHR inhibitor, alone and in combination with nivolumab in patients with locally advanced or metastatic solid tumors and urothelial ca... von McKean, Meredith, Aggen, David Henry, Lakhani, Nehal J., Bashir, Babar, Luke, Jason J., Hoffman-Censits, Jean H., Alhalabi, Omar, Bowman, Isaac Alex, Guancial, Elizabeth A., Tan, Alan, Lingaraj, Trupti, Timothy, Marissa, Kacena, Katherine, Malek, Karim S., Santillana, Sergio

Volltext

Immune-related adverse events are associated with improved outcomes in ICI-treated renal cell carcinoma patients von Elias, Roy, Yan, Flora, Singla, Nirmish, Levonyack, Nicholas, Formella, Joseph, Christie, Alana, Kapur, Payal, Bowman, Alex Isaac, Hammers, Hans J., Hannan, Raquibul, Brugarolas, James

Volltext

Safety and feasibility of nephrectomy after receipt of immune checkpoint inhibitors for renal cell carcinoma von Singla, Nirmish, Elias, Roy, Ghandour, Rashed, Freifeld, Yuval N, Bowman, Alex Isaac, Woldu, Solomon L., Gahan, Jeffrey, Bagrodia, Aditya, Brugarolas, James, Hammers, Hans J., Margulis, Vitaly

Volltext

Characterizing the outcomes of metastatic papillary renal cell carcinoma von Connor Wells, John, Donskov, Frede, Fraccon, Anna P, Pasini, Felice, Bjarnason, Georg A, Beuselinck, Benoit, Knox, Jennifer J, Rha, Sun Young, Agarwal, Neeraj, Bowman, Isaac Alex, Lee, Jae-Lyun, Pal, Sumanta K, Srinivas, Sandy, Scott Ernst, Douglas, Vaishampayan, Ulka N, Wood, Lori A, Simpson, Robin, De Velasco, Guillermo, Choueiri, Toni K, Heng, Daniel Y.C

Volltext